Tricidia Investors Win OK Of $14.2M Deal Over Kidney Drug
A California federal judge on Thursday granted final approval to a $14.2 million settlement that ends a class action against Tricidia founder Gerrit Klaerner claiming he and the company misled investors...To view the full article, register now.
Already a subscriber? Click here to view full article